Relationships among CYP3A4 and CYP3A5 haplotypes, mRNA expression, CYP3A activity and atorvastatin response in hypercholesterolemic individuals (2010)
- Authors:
- USP affiliated authors: HIRATA, MARIO HIROYUKI - FCF ; DOREA, EGIDIO LIMA - HU ; HIRATA, ROSARIO DOMINGUEZ CRESPO - FCF
- Unidades: FCF; HU
- Subjects: HIPERCOLESTEROLEMIA; POLIMORFISMO
- Language: Inglês
- Imprenta:
- Publisher place: Washington
- Date published: 2010
- Source:
- Título: Clinical Chemistry
- Volume/Número/Paginação/Ano: v. 56, n. 6 suppl., p. A89-A90 res. B-117, 2010
- Conference titles: American Association for Clinical Chemistry Annual Meeting/AACC
-
ABNT
WILLRICH, Maria Alice Vieira et al. Relationships among CYP3A4 and CYP3A5 haplotypes, mRNA expression, CYP3A activity and atorvastatin response in hypercholesterolemic individuals. Clinical Chemistry. Washington: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 12 fev. 2026. , 2010 -
APA
Willrich, M. A. V., Genvigir, F. D. V., Rodrigues, A. C., Arazi, S. S., Oliveira, R., Hirata, M. H., et al. (2010). Relationships among CYP3A4 and CYP3A5 haplotypes, mRNA expression, CYP3A activity and atorvastatin response in hypercholesterolemic individuals. Clinical Chemistry. Washington: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. -
NLM
Willrich MAV, Genvigir FDV, Rodrigues AC, Arazi SS, Oliveira R, Hirata MH, Dórea EL, Hirata RDC. Relationships among CYP3A4 and CYP3A5 haplotypes, mRNA expression, CYP3A activity and atorvastatin response in hypercholesterolemic individuals. Clinical Chemistry. 2010 ; 56( 6 suppl.): A89-A90 res. B-117.[citado 2026 fev. 12 ] -
Vancouver
Willrich MAV, Genvigir FDV, Rodrigues AC, Arazi SS, Oliveira R, Hirata MH, Dórea EL, Hirata RDC. Relationships among CYP3A4 and CYP3A5 haplotypes, mRNA expression, CYP3A activity and atorvastatin response in hypercholesterolemic individuals. Clinical Chemistry. 2010 ; 56( 6 suppl.): A89-A90 res. B-117.[citado 2026 fev. 12 ] - Leptin receptor gene polymorphisms are associated with adiposity and metabolic alterations in Brazilian individuals
- Influence of polymorphisms and cholesterol-lowering treatment on SCARB1 mRNA expression
- The contribution of genetic polymorphisms in 60 candidate genes to variability in atorvastatin response
- CYP3A5*3A allele is associated with reduced lowering-lipid response to atorvastatin in individuals with hypercholesterolemia
- Effects of atorvastatin on CYP3A4 and CYP3A5 mRNA expression in mononuclear cells and CYP3A activity in hypercholeresterolemic patients
- Pharmacogenetics of OATP transporters reveals that SLCO1B1 c.388A>G variant is determinant of increased atorvastatin response
- Influence of polymorphisms and cholesterol-lowering treatment on SCARB1 mRNA expression
- Differentiation of african components of ancestry to stratify groups in a case-control study of a brazilian urban population
- Apolipoprotein E mRNA expression in mononuclear cells from normolipidemic and hypercholesterolemic individuals treated with atorvastatin
- CYP3A4 and CYP3A5 mRNA expression in hypercholesterolemic individuals under hypolipemiant therapy
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
